ASSESSMENT OF SAFETY AND FEASIBILITY OF ROTATIONAL ATHERECTOMY (RA) VERSUS CONVENTIONAL STENTING IN PATIENTS WITH CHRONIC TOTAL OCCLUSION (CTO) LESIONS
DOI:
https://doi.org/10.54112/bcsrj.v2024i1.820Keywords:
Chronic Total Occlusion, Conventional Stenting, Myocardial Infarction, Rotational Atherectomy, SafetyAbstract
Chronic total occlusion (CTO) sores in coronary arteries present a challenge in percutaneous coronary intervention (PCI) because of their complex anatomy and high rates of procedural failure. Objectives: In this comparative study, we aim to investigate the safety and feasibility of rotational atherectomy (RA) versus conventional stenting in patients with chronic total occlusion (CTO) lesions. Methods: This comparative study was conducted at Ayub teaching hospital from September 2023 to December 2023. Data was collected from 110 patients from both genders. Patients aged > 18 years and diagnosed with chronic total occlusion (CTO) lesions in coronary arteries confirmed by coronary angiography were included in the study. Baseline demographic and clinical data, including age, gender, comorbidities, and angiographic characteristics, were collected for each participant. Additionally, procedural details such as the type of intervention, rotational atherectomy, conventional stenting, procedural time, fluoroscopy time, contrast volume, and any adverse events encountered during the procedure were recorded. Results: Data were collected from 110 patients from both genders. The mean age of participants in the Rotational Atherectomy (RA) group was 62.4 ± 7.3 years, while in the Conventional Stenting group, it was 61.8 ± 6.9 years. There were 40 males and 15 females in the RA group, compared to 38 males and 17 females in the Conventional Stenting group. The prevalence of diabetes mellitus was 42.0% in the RA group and 45.5% in the Conventional Stenting group. Left ventricular ejection fraction (LVEF) was 53.7 ± 4.2% in the RA group and 54.1 ± 4.5% in the Conventional Stenting group. The RA group showed a success rate of 81.8%, and the conventional stenting group achieved a success rate of 90.9%. However, the RA group experienced slightly higher rates of major procedural complications (9.1% vs. 5.5%) and minor procedural complications (12.7% vs. 10.9%) than the conventional stenting group. Conventional stenting group, the mean change was -1.2 ± 0.7. Additionally, the incidence of target lesion revascularisation (TLR) was observed in 8 patients (14.5%) in the RA group and 12 patients (21.8%) in the conventional stenting group. Furthermore, major adverse cardiovascular events (MACE) occurred in 9 patients (16.4%) in the RA group and 11 patients (20.0%) in the conventional stenting group. Conclusion: It is concluded that both rotational atherectomy (RA) and conventional stenting are effective and safe treatment options for patients with chronic total occlusion (CTO) lesions. Our findings suggest that both strategies yield comparable procedural success rates, complication rates, and efficacy outcomes, including myocardial infarction frequency, troponin levels, and left ventricular ejection fraction changes.
Downloads
References
Russo D, Massaro G, Benedetto D, Russo G, Canova P, Pescetelli I, Fiocca L, Romano M, Lettieri C, Chiricolo G, Sangiorgi GM. Contemporary approach to heavily calcified lesions: tools of the trade, challenges, and pitfalls. Vessel Plus. 2024; 8: 9. http://dx.doi.org/10.20517/2574-1209.2023.75
Xu, Rende, et al. "Procedural and In-hospital Outcomes of Rotational Atherectomy in Retrograde Coronary Chronic Total Occlusion Intervention." Angiology, 2020, https://doi.org/10.1177/0003319720949312.
Tsai TT, Stanislawski MA, Shunk KA, et al. Contemporary incidence, management, and long-term outcomes of percutaneous coronary interventions for chronic coronary artery total occlusions: insights from the VA CART program. JACC Cardiovasc Inter. 2017;10:866–75.
Brilakis ES, Mashayekhi K, Tsuchikane E, et al. They are guiding principles for chronic total occlusion percutaneous coronary intervention. Circulation. 2019;140:420–33.
Okamura A, Yamane M, Muto M, et al. Complications during retrograde approach for chronic coronary total occlusion: sub-analysis of Japanese multicenter registry. Catheter Cardiovasc Inter. 2016;88:7–14.
Tajti P, Karmpaliotis D, Alaswad K, et al. Prevalence, presentation and treatment of ‘balloon un dilatable’ chronic total occlusions: insights from a multicenter US registry. Catheter Cardiovasc Inter. 2018;91:657–66.
Brinkmann C, Eitan A, Schwencke C, et al. Rotational atherectomy in CTO lesions: too risky? Outcome of rotational atherectomy in CTO lesions compared to non-CTO lesions. Euro Intervention. 2018;14:e1192–e98.
Azzalini L, Dautov R, Ojeda S, et al. Long-term outcomes of rotational atherectomy for the percutaneous treatment of chronic total occlusions. Catheter Cardiovasc Inter. 2017;89:820–28.
Wang, Jing, et al. "Safety and Feasibility of Rotational Atherectomy for Retrograde Recanalization of Chronically Occluded Coronary Arteries." Frontiers in Cardiovascular Medicine, vol. 9, 2022, p. 854757, https://doi.org/10.3389/fcvm.2022.854757.
Ayoub, Mohamed, et al. "Safety and Efficiency of Rotational Atherectomy in Chronic Total Coronary Occlusion—One-Year Clinical Outcomes of an Observational Registry." Journal of Clinical Medicine, vol. 12, no. 10, 2022, p. 3510, https://doi.org/10.3390/jcm12103510.
Karacsonyi, J.; Stanberry, L.; Alaswad, K.; Krestyaninov, O.; Choi, J.W.; Rangan, B.V.; Nikolakopoulos, I.; Vemmou, E.; Ungi, I.; Brilakis, E.S. Predicting Technical Success of Chronic Total Occlusion Percutaneous Coronary Intervention: Comparison of 3 Scores. Circ. Cardiovasc. Interv. 2021, 14, e009860.
Tajti, P.; Karmpaliotis, D.; Alaswad, K.; Toma, C.; Choi, J.W.; Jaffer, F.A.; Doing, A.H.; Patel, M.; Mahmud, E.; Uretsky, B.; et al. Prevalence, Presentation and Treatment of ‘Balloon Undilatable’ Chronic Total Occlusions: Insights from a Multicenter US Registry. Catheter. Cardiovasc. Interv. 2018, 91, 657–666.
Brilakis, E.S.; Mashayekhi, K.; Tsuchikane, E.; Rafeh, N.A.; Alaswad, K.; Araya, M.; Avran, A.; Azzalini, L.; Babunashvili, A.M.; Bayani, B.; et al. Guiding Principles for Chronic Total Occlusion Percutaneous Coronary Intervention. Circulation 2019, 140, 420–433.
Huang, W.-C.; Teng, H.-I.; Chan, W.-L.; Lu, T.-M. Short-term and long-term clinical outcomes of rotational atherectomy in resistant chronic total occlusion. J. Interv. Cardiol. 2018, 31, 458–464.
Thygesen, K.; Alpert, J.S.; Jaffe, A.S.; Chaitman, B.R.; Bax, J.J.; Morrow, D.A.; White, H.D. Fourth Universal Definition of Myocardial Infarction (2018). Circulation 2018, 138, e618–e651.
Park, T.K.; Lee, S.H.; Choi, K.H.; Lee, J.M.; Yang, J.H.; Bin Song, Y.; Hahn, J.; Choi, J.; Gwon, H.; Lee, S.H.; et al. Late Survival Benefit of Percutaneous Coronary Intervention Compared With Medical Therapy in Patients With Coronary Chronic Total Occlusion: A 10-Year Follow-Up Study. J. Am. Hear. Assoc. 2021, 10, e019022.
Li, H.; Ai, H.; Li, L.; Zheng, N.; Tang, G.; Yang, G.; Zhao, Y.; Sun, F.; Zhang, H. The therapeutic effects of excimer laser coronary atherectomy therapy for in-stent restenosis chronic total occlusions. BMC Cardiovasc. Disord. 2021, 21, 399.
Abdelaziz, A., Elsayed, H., Hamdaalah, A. et al. Safety and feasibility of rotational atherectomy (RA) versus conventional stenting in patients with chronic total occlusion (CTO) lesions: a systematic review and meta-analysis. BMC Cardiovasc Disord 24, 4 (2024). https://doi.org/10.1186/s12872-023-03673-2
Dash D. Interventional Management of ‘Balloon-Uncrossable’ Coronary Chronic Total Occlusion: is there any way out? Korean Circ J. 2018;48(4):277. https://doi.org/10.4070/kcj.2017.0345
McQuillan C, Jackson MWP, Brilakis ES, Egred M. Uncrossable and undeletable lesions—A practical approach to optimising outcomes in < scp > PCI, Catheterization and Cardiovascular Interventions, vol. 97, no. 1, pp. 121–126, Jan. 2021, https://doi.org/10.1002/ccd.29001
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 SB SHAH , S AHMED , MU KHAN , SK KHAN , RFF ALRASHED
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.